In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

Hollywood-based AIDS Healthcare Foundation has won a $10.3 million arbitration award in a dispute with a pharmacy benefit ...

A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...

As PBM services have traditionally been dominated by large companies such as CVS Caremark, Express Scripts and OptumRx, health systems are starting to create alternatives. Here are four more things to ...

NEW YORK, Jan. 14 (Xinhua) -- The largest pharmacy-benefit managers (PBMs) hiked the prices of certain drugs dispensed through their own pharmacies, according to a new report by the Federal Trade ...

Whether the payer is a for-profit PBM in the U.S. or a single-payer government ... Are there other goods and services, such as medication therapy management, that pharmacies could provide that ...

NEW YORK, Jan. 14 (Xinhua) -- The largest pharmacy-benefit managers (PBMs) hiked the prices of certain drugs dispensed through their own pharmacies, according to a new report by the Federal Trade ...

These companies are considered the “Big 3” in the PBM industry, controlling roughly ... Ownbey spoke on behalf of the Pharmaceutical Care Management Association (PCMA), a trade organization ...

US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain By Ahmed Aboulenein and Amina Niasse WASHINGTON (Reuters) -The nation's three largest pharmacy benefit ...